The objective of this study was to compare and contrast characteristics of healthcare-associated community onset bloodstream infections with community-acquired and hospital-acquired bloodstream infections. Researchers assessed 7,712 patients, of which 2,132 (28 percent) had hospital-acquired infections, 2,492 (32 percent) healthcare-associated community onset infections and 3,088 (40 percent) had community acquired infections.
Their analysis showed patients with community-acquired infections were significantly younger and less likely to have co-morbid medical illnesses than patients with hospital-acquired or community onset infections. The median length of stay and all-cause mortality rates differed for each category of infections as well.
The researchers concluded healthcare-associated community onset infections are distinctly different from community-acquired and hospital-acquired infections based on a number of epidemiologic, microbiologic and outcome characteristics.
Related Articles on Infection Control:
Patients Test Negative for Blood Infections From Poor Quality at Shuttered Cancer Center
Adoption of CAUTI Prevention Strategies Falls Short
Steam Vapor May Be Effective Means for Environmental Disinfection
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
